Analysts Set GSK plc (LON:GSK) Target Price at GBX 1,805.83

GSK plc (LON:GSK - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven brokerages that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is GBX 1,805.83 ($22.69).

GSK has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a GBX 1,850 ($23.25) price target on shares of GSK in a report on Tuesday, September 3rd. Shore Capital reissued a "buy" rating on shares of GSK in a research report on Wednesday, August 28th. JPMorgan Chase & Co. restated an "underweight" rating on shares of GSK in a report on Wednesday, December 11th. Finally, Berenberg Bank decreased their price objective on shares of GSK from GBX 1,820 ($22.87) to GBX 1,600 ($20.11) and set a "buy" rating for the company in a research note on Friday, November 29th.

Insider Transactions at GSK

In related news, insider Jonathan Symonds purchased 7,150 shares of the business's stock in a transaction that occurred on Wednesday, October 30th. The shares were acquired at an average price of GBX 1,394 ($17.52) per share, for a total transaction of £99,671 ($125,262.03). Also, insider Elizabeth (Liz) McKee Anderson acquired 446 shares of the firm's stock in a transaction on Monday, September 23rd. The stock was bought at an average price of GBX 2,051 ($25.78) per share, with a total value of £9,147.46 ($11,496.12). In the last ninety days, insiders acquired 7,604 shares of company stock worth $10,893,038. 1.61% of the stock is currently owned by insiders.

GSK Stock Down 1.0 %

Shares of GSK stock traded down GBX 13.50 ($0.17) during trading on Friday, reaching GBX 1,308.50 ($16.44). 14,335,906 shares of the company traded hands, compared to its average volume of 9,987,883. The firm has a market capitalization of £53.39 billion, a PE ratio of 1,157.96, a P/E/G ratio of 1.24 and a beta of 0.31. GSK has a 1-year low of GBX 1,282.50 ($16.12) and a 1-year high of GBX 1,823.50 ($22.92). The company has a 50 day moving average price of GBX 1,390.68 and a 200-day moving average price of GBX 1,511.92. The company has a debt-to-equity ratio of 123.04, a current ratio of 0.82 and a quick ratio of 0.73.

GSK Announces Dividend

The company also recently announced a dividend, which will be paid on Thursday, January 9th. Investors of record on Thursday, November 14th will be given a GBX 15 ($0.19) dividend. The ex-dividend date of this dividend is Thursday, November 14th. This represents a yield of 1.03%. GSK's payout ratio is 5,309.73%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.